Skip to main content
Smart Investors Daily
RF

NASDAQ · RFL

Rafael Holdings, Inc.

Real Estate · Real Estate - Services

$1.07

Down-$0.04 (-3.60%)

Updated Nov 16, 2026, 5:27 AM

SID Score

3.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
52.46M
P/E ratio
-1.65
Dividend yield
0.00%
52-week range
$0.99 – $3.96
Volume
27.56K
Avg. volume
125.73K

Price performance · RFL

RFL price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 13, 2026

RFL closed at $1.07 after 20 trading sessions, down 17.05% for the selected period.

Last close
$1.07
Period change
-17.05%
Period low
$1.00
Period high
$1.31
Daily close
View OHLC price history
RFL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 13, 2026$1.07$1.11$1.03$1.0727.56K
Nov 12, 2026$1.05$1.115$1.05$1.1127.5K
Nov 11, 2026$1.09$1.13$1.09$1.0924.99K
Nov 10, 2026$1.08$1.11$1.0326$1.07116.03K
Nov 9, 2026$1.01$1.172$1.01$1.0847.75K
Nov 6, 2026$1.05$1.095$0.9901$1.0443.28K
Nov 5, 2026$1.102$1.20$1.05$1.0694.38K
Nov 4, 2026$1.05$1.13$1.05$1.0755.75K
Nov 3, 2026$1.08$1.16$1.02$1.08146.69K
Nov 2, 2026$1.08$1.12$0.9928$1.0098.37K
Oct 30, 2026$1.15$1.23$1.08$1.0867.24K
Oct 29, 2026$1.16$1.265$1.085$1.12139.51K
Oct 28, 2026$1.23$1.2895$1.21$1.2132.21K
Oct 27, 2026$1.20$1.30$1.18$1.2445.48K
Oct 26, 2026$1.345$1.345$1.1723$1.1860.33K
Oct 23, 2026$1.29$1.315$1.23$1.3153.67K
Oct 22, 2026$1.27$1.285$1.25$1.2837.06K
Oct 21, 2026$1.31$1.3596$1.23$1.3045.01K
Oct 20, 2026$1.29$1.3499$1.2891$1.2932.47K
Oct 19, 2026$1.36$1.38$1.28$1.2976.4K

Latest RFL news

The latest Smart Investors Daily articles mentioning RFL.

RFL research

Overview

Company profile and research snapshot.

Company profile

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.